Center for Financial Planning’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.92K Hold
209
﹤0.01% 512
2026
Q1
$13.1K Hold
209
﹤0.01% 463
2025
Q4
$19.9K Hold
209
﹤0.01% 416
2025
Q3
$20.4K Hold
209
﹤0.01% 414
2025
Q2
$22.4K Hold
209
﹤0.01% 382
2025
Q1
$21.1K Hold
209
﹤0.01% 387
2024
Q4
$18.7K Buy
209
+79
+61% +$6.95K ﹤0.01% 356
2024
Q3
$10.9K Hold
130
﹤0.01% 395
2024
Q2
$10K Buy
+130
New +$9.52K ﹤0.01% 396
2022
Q2
Sell
-19
Closed -$1K 535
2022
Q1
$1K Hold
19
﹤0.01% 492
2021
Q4
$1K Buy
+19
New +$798 ﹤0.01% 501
2020
Q2
Sell
-68
Closed -$2K 469
2020
Q1
$2K Buy
+68
New +$2.66K ﹤0.01% 484

Other funds holding BSX

Center for Financial Planning's BSX Position: Q2 2026 in Review

Center for Financial Planning held its Boston Scientific (BSX) position steady in Q2 2026 at 209 shares worth $8.92K. The position accounts for ﹤0.01% of the portfolio, ranked #512.

Center for Financial Planning first reported a position in BSX in Q1 2020 and has held it in 12 quarters since. The position peaked at $22.4K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Center for Financial Planning held 209 shares of Boston Scientific worth $8.92K as of Q2 2026.
  • Center for Financial Planning left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Center for Financial Planning's portfolio in Q2 2026, its #512 holding.
  • Center for Financial Planning first reported a position in Boston Scientific in Q1 2020 and has held it in 12 quarters since.
  • Center for Financial Planning's Boston Scientific position peaked at $22.4K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Center for Financial Planning's 13F filing for Q2 2026, filed 21 Jul 2026.